NIKKEI 225
38,782.08 -138.18 (-0.36%) HANG SENG
19,347.48 -29.05 (-0.15%) CRUDE OIL
79.28 +0.05 (+0.06%) GOLD FUTURES
2,379.60 -5.90 (-0.25%) DOW
39,869.38 -38.62 (-0.10%) Bitcoin GBP
51,668.50 -438.15 (-0.84%)
Compugen Ltd. (CGEN)
After hours:
| Previous close | 2.2100 |
| Open | 2.1800 |
| Bid | 2.1000 x 100 |
| Ask | 2.1500 x 300 |
| Day's range | 2.1200 - 2.1928 |
| 52-week range | 0.5300 - 3.0300 |
| Volume | |
| Avg. volume | 461,664 |
| Market cap | 194.688M |
| Beta (5Y monthly) | 2.72 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2100 |
| Earnings date | 20 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.33 |
PR NewswireCompugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential
Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the online publication of a peer reviewed paper titled "PVRIG is expressed on stem-like T cells in dendritic cell-rich niches in tumors and its blockade may induce immune infiltration in non-inflamed tumors" link, in Cancer Immunology Research, a journal of the American Association for Cancer Research.
PR NewswireCompugen Appoints David Silberman as Chief Financial Officer
Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the appointment of David Silberman as its new Chief Financial Officer effective August 15, 2024, taking over from Alberto Sessa who will depart Compugen on the same day. David will join Compugen from Oramed Pharmaceuticals Inc., where he served as Chief Financial Officer.
PR NewswireCompugen to Release First Quarter 2024 Results on Monday, May 20, 2024
Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Company will release its first quarter 2024 financial results on Monday, May 20, 2024, before the U.S. financial markets open. Management will host a conference call and webcast to review the results and provide a corporate update at 8:30 AM ET.
